Dr Reddy's generic opioid addiction drug launch faces court hurdle in US

Dr Reddy's recently announced the launch of Buprenophine and Naloxone Sublingual Film, a generic equivalent of Suboxone

Dr Reddy's Laboratories Limited on Saturday announced that following the launch of its generic Buprenophine and Naloxone Sublingual Film in the US market, the US District Court for the District of New Jersey has issued a temporary restraining order and preliminary injunction against the company in a current patent litigation. 

Pending a hearing and decision on the injunction application filed by Indivior PLC, the court has issued a temporary restraining order against Dr Reddy's with respect to further sales and commercialisation of the drug, which is used to treat adults with opioid dependence/addiction.

"The court order does not include prohibition on commercial